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Abstract  
Background 
Hallux valgus (HV) is a very common deformity of the first metatarsophalangeal joint that 
often requires surgical correction. However, the association between structural HV deformity 
and related foot pain and disability is unclear. Furthermore, no previous studies have 
investigated concerns about appearance and difficulty with footwear in a population with HV 
not seeking surgical correction. The aim of this cross-sectional study was to investigate foot 
pain, functional limitation, concern about appearance and difficulty with footwear in 
otherwise healthy adults with HV compared to controls. 
Methods 
Thirty volunteers with HV (radiographic HV angle >15 degrees) and 30 matched controls 
were recruited for this study (50 women, 10 men; mean age 44.4 years, range 20 to 76 years). 
Differences between groups were examined for self-reported foot pain and disability, 
satisfaction with appearance, footwear difficulty, and pressure-pain threshold at the first 
metatarsophalangeal joint. Functional measures included balance tests, walking performance, 
and hallux muscle strength (abduction and plantarflexion). Mean differences (MD) and 95% 
confidence intervals (CI) were calculated. 
Results 
All self-report measures showed that HV was associated with higher levels of foot pain and 
disability and significant concerns about appearance and footwear (p < 0.001). Lower 
pressure-pain threshold was measured at the medial first metatarsophalangeal joint in 
participants with HV (MD = -133.3 kPa, CI: -251.5 to -15.1). Participants with HV also 
showed reduced hallux plantarflexion strength (MD = -37.1 N, CI: -55.4 to -18.8) and 
abduction strength (MD = -9.8 N, CI: -15.6 to -4.0), and increased mediolateral sway when 
standing with both feet with eyes closed (MD = 0.34 cm, CI: 0.04 to 0.63). 
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Conclusions 
These findings show that HV negatively impacts on self-reported foot pain and function, and 
concerns about foot appearance and footwear in otherwise healthy adults. There was also 
evidence of impaired hallux muscle strength and increased postural sway in HV subjects 
compared to controls, although general physical functioning and participation in physical 
activity were not adversely affected. 
Keywords 
hallux valgus, foot pain, physical function, footwear 
 - 4 - 
Background 
 
Hallux valgus (HV) is a progressive foot deformity presenting with lateral deviation of the 
hallux and medial deviation of the first metatarsal head. Increasing HV severity is associated 
with subluxation of the first metatarsophalangeal joint (MTPJ) and presence of osteoarthritis 
(OA) [1]. HV is very common, affecting approximately 23% of adults [2], and surgical 
correction is frequently sought, making HV the most common indication for orthopaedic 
forefoot surgery [3]. 
 
While HV is basically regarded as a structural deformity, there is debate surrounding the 
association between abnormal foot structure and related pain and disability. Several studies in 
elderly populations have found no association between HV and self-reported foot pain and 
disability [4-9]; whereas, another study reported a significant association between HV and 
disabling foot pain in older adults [10]. Although fewer studies have investigated these 
associations in populations with a wide age range, recent studies have linked HV to greater 
self-reported foot pain and functional limitation in adults aged 40 to 69 years [11], and big 
toe pain in adults aged over 30 years [12]. Furthermore, there is evidence for impaired quality 
of life associated with HV and big toe pain in adults aged over 30 years [13], and poorer 
health-related quality of life and greater foot pain and disability with increasing HV severity 
in adults aged over 50 years [14]. 
 
In addition to self-reported pain and disability, the impact of HV on functional performance 
has been investigated with inconsistent findings. Impaired balance and gait patterns, toe 
muscle weakness, and an increased risk of falls in elderly individuals with moderate or severe 
HV have been reported by several studies [8, 15-21]; however, other studies have shown no 
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association between HV and postural sway [22], walking performance [4, 6] or history of 
falls [5].  No previous studies have reported on physical measures of functional performance 
in adults of all ages with HV. 
 
Two additional factors considered most important by patients and orthopaedic surgeons are 
concerns about cosmetic appearance and difficulty with footwear [23, 24]. While a few 
population studies have investigated footwear factors such as past usage of high-heeled shoes 
[9] and shoe fit [5, 25], no previous studies have investigated self-reported difficulty with 
footwear or concerns about foot appearance in individuals with HV not seeking surgical 
correction. Therefore, the primary aim of this cross-sectional study was to investigate 
differences in foot pain, functional limitation, concerns about appearance and difficulty with 
footwear in a group of adults with HV compared to matched controls. A secondary aim was 
to explore possible associations between these variables and severity of deformity in HV 
subjects. 
 
Methods 
 
Subjects 
 
Thirty volunteers with HV (aged 20 years and older) and 30 controls matched for age (± 5 
years), gender, and body mass index (BMI) (± 5 kg/m2) were recruited for participation in 
this study through community advertisements. Exclusion criteria were: history of foot or 
ankle surgery or fractures, hallux limitus (self-reported or first MTPJ passive dorsiflexion 
range of motion < 50 degrees) [26], inflammatory disease, neurological conditions, and a 
history of falls. Because radiographs were required to measure HV angle and determine 
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inclusion into HV or control groups, pregnant or breastfeeding women were also excluded 
from this study.  Weight-bearing dorsoplantar radiographs of both feet were obtained for all 
eligible participants by the same radiographer using a GE Definium 6000 Digital X-ray 
system. The HV angle (measured as the angle between the first metatarsal and proximal 
phalanx) [27] was determined from digital radiographs using computer software developed 
for telemedical applications [28], and HV cases were defined as an angle greater than 15 
degrees. To be eligible for the control group, participants were required to have a 
radiographic HV angle less than 15 degrees on both feet. Radiographs were further examined 
by another examiner for signs of osteophytes and joint space narrowing with reference to a 
radiographic atlas developed by Menz et al. [29]. The case definition defined by these authors 
was used to classify cases of first MTPJ OA. Ethical approval was gained from the 
institutional Medical Research Ethics Committee, and all subjects gave written informed 
consent prior to participation. 
 
Measurement procedure 
 
Height, weight and body mass index (BMI) were recorded in order to match HV participants 
with controls, and demographic data were obtained via questionnaire. All examinations and 
questionnaires were administered by a single examiner (SN). Intra-rater reliability for 
physical measures was determined from pilot work. Refer to Additional file 1 for intraclass 
correlation coefficients (ICC3,1), standard error of measurement (SEM), and minimum 
detectable change at the 90% confidence limit. Reliability was considered good for ICCs 
greater than 0.75, and very good for ICCs greater than 0.9 [30]. 
 
General health and physical activity 
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General health and well-being were assessed using the Short Form 36 Health Survey (SF-
36v2®), which includes eight subscales [31]. Habitual physical activity levels were assessed 
using the Baecke Questionnaire [32] to calculate a work index, sport index, and leisure index. 
 
Self-reported foot pain and disability 
 
To investigate functional disability related to foot pain, participants completed the Foot 
Health Status Questionnaire (FHSQ) [33] and Manchester Foot Pain and Disability Index 
(FPDI) [34]. The FHSQ contains four domains: foot pain (4 items), foot function (4 items), 
footwear (3 items), and general foot health (2 items). This questionnaire has been validated 
and shown to have good test-retest reliability [33]. FHSQ subscale scores are converted to a 
scale ranging from 0 to 100, with higher scores indicating better foot health. The original 
FPDI contained 19 items [34]; however, recent psychometric evaluation [35, 36] has shown 
that 17 items cluster around three main constructs: functional limitation (10 items), pain 
intensity (5 items), and appearance (2 items). While different methods have been used for 
FPDI scoring [36], we used the approach described by Menz et al. [37]. Responses to 
questionnaire items were coded as follows: “none of the time” = 0, “some days” = 1, “on 
most/every day” = 2. A total score was calculated as the sum of item responses, resulting in 
an ordinal scale ranging from 0 to 34, and subscales were calculated for pain (score range 0 to 
10) and function (score range 0 to 20). 
 
Visual analogue scales (VAS) were used to investigate foot pain intensity and concerns about 
appearance. Worst and average foot pain intensity over the past four weeks were evaluated 
using a 100 mm VAS, with 0 mm described as “no pain” and 100 mm described as “worst 
pain ever,” and the pain location was identified on a foot diagram. The pain VAS has well-
established reliability and validity in lower limb musculoskeletal research [38]. Participants 
 - 8 - 
were also asked to indicate how satisfied they were with the appearance of their feet on a 100 
mm VAS, with 0 mm representing “completely satisfied with appearance” and 100 mm 
representing “completely dissatisfied with appearance.” This method was adapted from a 
technique described by Saro et al. [39]. 
 
Footwear 
 
Participants were asked to wear their regular footwear to the examination session. Shoes were 
assessed using a steel ruler to measure relative heel height (the difference between heel height 
and forefoot sole thickness) [25] and using digital callipers for relative ball width (the 
difference between forefoot width across the widest point of the MTPJs and the width of the 
shoe upper at the same point). A positive value for relative ball width indicated that the shoe 
upper was wider than the forefoot. Participants who wore sandals that were unable to be 
measured in this manner (n = 12) were excluded from this analysis. Finally, participants were 
asked whether they had ever regularly worn shoes with a heel height greater than two inches 
(yes/no), and how often they currently wore this style of shoe (never, seldom, sometimes, 
often, always) [25]. 
 
Pressure-pain threshold 
 
In order to obtain a quantifiable measurement of tenderness around the first MTPJ, as a 
surrogate for clinical palpation, pressure-pain threshold (PPT) was measured at the medial 
and plantar aspects of the joint. A digital pressure algometer (Somedic AB, Farsta, Sweden) 
was used to measure the pressure applied at a rate of 40kPa/s by a rubber-tipped probe (area 
1cm2) [40]. An average of three measurements from each site was used for analysis. 
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Functional performance and muscle strength 
 
Participants were asked to walk along a 10 metre walkway, and ascend and descend a set of 
10 stairs (17.5cm high and 26cm deep) as quickly as possible. Each test was completed 
barefoot (without shoes or socks). The tests were recorded in seconds and the fastest of three 
trials was used for analysis. Similar functional performance tests have been used with good 
reliability in previous research [8]. Postural sway was examined using a force plate (Model 
4060-07, Bertec, USA) and six different standing conditions: both feet on a firm surface with 
eyes open and closed, both feet on high-density foam (0.10 kg/cm3; 15 cm thickness) with 
eyes open and closed, and single leg stance on a firm surface with eyes open (left and right). 
A 70 second trial was completed for each condition [41]. If the subject was unable to 
complete the trial, a minimum of 30 seconds was required for the trial to be included in 
analysis. Data was analysed using Matlab (version 7.9; MathWorks, Natick, USA), and 
variables analysed were range of centre of pressure (COP) in both mediolateral and 
anteroposterior directions. Hallux plantarflexion and abduction strength were evaluated using 
50 kg load cells (GK 2126-50, Gedge Systems, Melbourne, Australia) mounted in a custom-
built frame (Figure 1). The load cells were calibrated prior to each measurement session, and 
the signal converted to force (N). Participants were seated with the knee in 30 degrees of 
flexion and the lower leg and foot stabilised using Velcro straps. After familiarisation with 
the required movements, participants were asked to perform three maximum isometric 
voluntary contractions in hallux plantarflexion and abduction. The examiner ensured that the 
subject’s heel remained in contact with the base of the frame and that there was minimal 
activity of lower leg muscles. The maximum force achieved over three trials was used for 
analysis. 
 
 - 10 - 
Sample size determination 
 
Sample size was based on a priori power calculations. Using standard deviations obtained 
from preliminary data analysis (n = 26), we determined that 29 subjects in each group would 
provide 80% power to detect a difference of 11 mm between groups on the 100 mm pain 
VAS (alpha 0.05) [42, 43]. 
 
Statistical analysis 
 
Age and BMI were first compared using independent t-tests to ensure that there were no 
significant differences between HV and control groups. For variables measured bilaterally 
(appearance VAS, hallux strength, PPT, and postural sway in single leg stance), data from 
only one limb was analysed [44]. For HV subjects the foot with a greater HV angle was 
chosen (16 right feet and 14 left feet used for analysis), while for control subjects the right or 
left foot was chosen at random using a random number generator (15 right feet and 15 left 
feet used for analysis). All variables were examined for normality of distribution using 
boxplots, histograms, and quantile-normal plots. Continuous variables showing a skewed 
distribution were transformed wherever possible using log, square root, or inverse square root 
transformations, as appropriate. Differences between groups were then examined using 
independent t-tests for continuous variables, Wilcoxon rank-sum tests for ordinal variables 
and continuous variables for which no adequate transformation was available, and Chi-
squared statistics for categorical data. In the HV group (n = 30), the relationship between HV 
angle and other variables was investigated using Spearman’s correlation coefficient. 
Correlations are reported for variables showing statistically significant correlations with HV 
angle. Spearman’s rho was interpreted as follows: low correlation (rho = 0.26 to 0.49), 
moderate correlation (rho = 0.5 to 0.69) or high correlation (rho > 0.7) [45]. Results for 
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continuous variables are presented as means, standard deviations (SD), mean differences 
(MD), and 95% confidence intervals (CI), while ordinal data are presented as medians (min – 
max). All analyses were conducted using STATA version 10 [46], and the level of 
significance was set at p < 0.05. 
 
Results 
 
Subjects 
 
Mean age of the total sample was 44.4 years (SD 15.1, range 20 to 76 years) and mean BMI 
was 24.5 kg/m2 (SD 3.8, range 18.0 to 35.4 kg/m2), with HV and control groups matched on 
these characteristics. The mean absolute difference between matched subjects for age was 1.6 
years and for BMI was 1.7kg/m2. There were 25 women and five men in each group. Subject 
characteristics, as well as radiographic HV angle and presence of first MTPJ OA in each 
group are presented in Table 1. 
 
General health and physical activity 
 
There were no significant differences between HV and control groups for SF-36v2® 
subscales, although the difference between groups on the vitality subscale (MD = -7.7, CI: -
15.6 to 0.11) approached statistical significance (p = 0.05). HV participants reported 
significantly higher sporting activity (MD = 0.69, CI: 0.28 to 1.1) and physical activity levels 
at work (MD = 0.17, CI: 0.0 to 0.33), while the leisure index was not significantly different 
between groups (Table 1). 
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Foot pain and disability 
 
Significant between-group differences were found for all measures of self-reported foot pain 
and disability, including FHSQ and FPDI subscales (Table 2). Participants with HV reported 
more foot pain over the past four weeks on a 100mm VAS for worst pain (MD = 25.5 mm, 
CI: 14.3 to 36.6) and average pain (MD = 12.3 mm, CI: 6.2 to 18.3). PPT was lower at the 
medial first MTPJ in participants with HV (MD = -133.3 kPa, CI: -251.5 to -15.1), although 
there was no significant difference in PPT at the plantar first MTPJ. 
 
Analysis of foot pain locations showed that 25 HV subjects (83%) reported pain in the first 
MTPJ or hallux, eight subjects (27%) reported pain in the lesser toes or MTPJs, and six 
subjects (20%) reported pain in the heel or midfoot area. There were 12 HV subjects who 
reported foot pain in more than one location, and only two who reported no foot pain. Control 
subjects reported the following distribution of foot pain: pain under the first MTPJ (one 
subject, 3%), pain in the lesser toes or MTPJs (nine subjects, 30%), and pain in the heel or 
midfoot (13 subjects, 43%). Three control subjects reported pain in more than one location, 
and nine reported no foot pain. 
 
Concerns about appearance and footwear 
 
Participants with HV had significant concerns about foot appearance (VAS: MD = 38.1 mm, 
CI: 23.8 to 52.3) and more difficulty fitting footwear (FHSQ footwear score: MD = -47.5, CI: 
-60.0 to -34.9) than control subjects. On the FPDI item which states “I feel self-conscious 
about my feet”, 19 participants with HV (63%) responded “on some days” or “on most/every 
day”, compared to five participants (17%) in the control group (Chi-squared p = 0.001). 
Similarly, 13 HV participants (43%) responded positively to the statement “I get self 
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conscious about the shoes I have to wear”, compared to one participant (3%) in the control 
group (Chi-squared p = 0.001). Fifteen participants in the HV group and 16 control 
participants reported a history of regularly wearing high heeled shoes (> 2 inches). Eight 
participants in each group reported wearing high heels “sometimes,” while high heels were 
worn “often” by four control participants and two HV participants, and “always” by one 
person with HV. Examination of footwear worn to the examination session showed no 
significant differences between groups in relative heel height or relative ball width measures 
(p > 0.05) (Table 2). 
 
Functional performance and muscle strength 
 
Functional performance measures are presented in Table 3. There were no significant 
differences in walking performance between groups (p > 0.05). Mediolateral sway while in 
double-leg stance on a firm surface with eyes closed was the only postural sway parameter 
that was different between groups, with a significant increase in mediolateral COP range in 
the HV group compared to controls (p = 0.03). In single leg stance, seven subjects (4 HV, 3 
controls) were unable to complete the entire 70-second trial, and two of these trials (< 30 sec) 
were excluded from analysis. As shown in Figure 2, the HV group had significantly weaker 
hallux plantarflexion strength (MD = -37.1 N, CI: -55.4 to -18.8) and hallux abduction 
strength (MD = -9.8 N, CI: -15.6 to -4.0) compared to controls. 
 
Correlations with HV angle 
 
A significant inverse correlation was found between greater HV angles and lower FHSQ 
scores indicating poorer general foot health (rho = -0.41, p = 0.03). Greater HV angles were 
correlated with higher appearance VAS scores indicating less satisfaction with appearance 
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(rho = 0.43, p = 0.02).  There was also a significant inverse correlation between greater HV 
severity and poorer hallux abduction strength (rho = -0.41, p = 0.03). Across the SF-36v2® 
subscales, low correlations were found between HV angle and bodily pain (rho = 0.39, p = 
0.04) and social functioning (rho = 0.49, p = 0.01), indicating that in our sample,  HV 
subjects with more severe deformity reported less bodily pain and better overall social 
functioning. No significant correlations were found for other SF-36v2® subscales, and HV 
angle was not correlated with footwear difficulty or any other measure of foot pain and 
function (i.e. FHSQ, FPDI, VAS, PPT). 
 
Discussion 
 
This study investigated self-reported foot pain and disability, functional performance, 
concerns about appearance and difficulty with footwear experienced by healthy adults with 
HV. We secondarily explored possible associations between severity of HV angle and other 
variables in participants with HV. 
 
Our results show that the presence of HV deformity is associated with self-reported foot pain 
and disability. Significant differences were found between HV and control groups for FHSQ 
and FPDI subscales, as well as worst and average pain VAS (Table 2). With reference to the 
minimal important difference for the FHSQ and VAS previously reported by Landorf et al. 
[43], these differences between groups can be considered clinically meaningful. Our findings 
are similar to those reported by Cho et al. [11] who showed that HV was associated with 
more self-reported foot pain and poorer self-reported physical functioning in adults aged 40 
years and older (n = 563). Abhishek et al. [13] further highlighted the importance of big toe 
pain accompanying HV, reporting that health-related quality of life was progressively 
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impaired in adults aged 30 years and older (n = 3082) with HV alone, big toe pain alone, and 
HV with big toe pain. In our study there was also some evidence of mechanical hyperalgesia 
around the medial aspect of the first MTPJ, as indicated by a lower PPT in HV subjects (p < 
0.05). However, this result should be interpreted with caution as the difference between 
groups (MD = -133.3, CI: -251.5 to -15.1) did not reach the calculated MDC90 (255.2) 
(Additional file 1) and therefore may not represent a meaningful difference. 
 
In addition to self-reported foot pain and functional limitation, participants with HV in our 
study presented with hallux plantarflexion and abduction weakness and increased 
mediolateral postural sway. Our finding of decreased hallux plantarflexion strength in people 
with HV is consistent with that of Mickle et al. [21]. However, our study also showed a 
significant inverse correlation between HV angle and an individual’s ability to abduct the 
hallux (rho = -0.41), a finding which has been suggested by electromyographic investigations 
[47, 48] but previously has not been investigated clinically. With regard to standing balance, 
results reported by Mickle et al. [22] are in contrast to our findings, as these authors reported 
no difference in postural sway between older adults with HV and controls. However, other 
studies in elderly populations have found poorer lateral stability, poorer coordinated stability, 
and increased postural sway to be associated with HV [17, 19]. Finally, no significant 
between-group differences were found in walking performance in our study, which is 
consistent with previous findings in elderly populations [4, 5, 8, 19]. 
 
Despite no differences between groups in relative heel height or relative ball width of 
footwear worn to the examination, participants with HV reported significantly more difficulty 
with footwear and concerns about foot appearance than controls. Concerns about appearance 
and general foot health appeared to increase with severity of deformity in the HV group 
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(appearance VAS: rho = 0.43, FHSQ general foot health: rho = -0.41). To our knowledge, 
this is the first study to investigate self-reported difficulty with footwear and concerns about 
appearance in a HV population not seeking surgical correction compared to age and gender-
matched controls. Our data suggest that clinicians managing HV should place particular 
priority on footwear concerns. This is supported by Saro et al. [24], who showed that free 
choice of footwear was significantly associated with health-related quality of life outcomes 
after HV surgery. 
 
While participants with HV in our study reported significantly more foot-specific functional 
disability, participation in physical activities, general health and physical functioning were 
not adversely affected (Table 1). To the contrary HV subjects reported higher levels of 
habitual physical activity at work and in sports, which may have led to improved 
performance on other physical parameters such as walking and balance tests. Furthermore, 
correlations between HV angle and SF-36v2® subscales suggest that in our sample HV 
participants with more severe deformity experienced less bodily pain and better social 
functioning. This finding is in contrast to results of a recent study by Menz et al. [14] who 
found a trend towards poorer scores on all SF-36v2® subscales with increasing HV severity in 
adults aged 50 years and older (n = 2681). It is possible that general health and functioning 
may be more impacted by increasing HV severity in populations of older adults; alternatively, 
it may be that our findings were a consequence of a volunteer sample of HV participants, 
who were active individuals with a high level of physical functioning. Furthermore, perhaps 
those with more severe HV in our sample had adapted their lifestyle or footwear choices to 
accommodate for a severe foot deformity. 
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Caution must be applied when comparing reports from different studies as varying case 
definitions (present/absent or mild/moderate/severe) and means of diagnosing HV (i.e. self-
reported or diagnosed by an examiner) are used [2]. Studies have used a range of methods to 
evaluate the presence and severity of HV, including weight-bearing radiographs [11, 49], and 
the Manchester Scale [10, 17, 19, 22, 50], which includes a series of four standardised 
photographs used by an examiner to classify HV as “none,” “mild,” “moderate,” or “severe.” 
Other larger studies have used a validated self-report instrument based on five line drawings 
representing increasing HV severity [12-14, 51]. Our study used standardised weight-bearing 
radiographs and a widely accepted angular definition to classify HV as being present (HV 
angle > 15°) [52]. This definition meant that several mild and asymptomatic HV cases were 
included, which was considered appropriate to address the primary research question of 
whether the presence of HV was associated with foot pain and disability. 
 
Our study findings should be interpreted with consideration of our recruitment methods and 
sample, which may affect the generalisability of results. First, volunteers with HV responding 
to advertisements were likely aware that they had a foot problem. This may have introduced 
an element of bias to their self-reported foot health measures compared to controls. Second, 
only ten males participated in this study, and the age range of study participants was 
relatively wide. Nevertheless, these sample characteristics were considered representative of 
a clinical population. Third, whilst our sample included participants with mild, moderate and 
severe HV, the sample size in the current study was not sufficient to examine subgroups 
according to HV severity. While there is some evidence that increasing HV severity has a 
greater impact on foot pain and disability [14], further research using large population-based 
samples is warranted to determine whether HV severity is associated with increased foot pain 
or poorer functional performance. 
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Reliability of measurement methods must be considered as a potential limitation in any 
clinical research. All measurements in our study were performed by the same examiner, and 
intra-rater reliability was very good for most physical measurements (Additional file 1). 
Inter-rater reliability was not addressed by this investigation. Reported intra-rater reliability 
for hallux plantarflexion and abduction strength was lower than desirable (ICC3,1 = 0.73 to 
0.75), and as a result the calculated values for MDC90 (plantarflexion: 47.8 N; abduction: 14.5 
N) were quite large for these measures. While the differences between HV and control groups 
were statistically significant (plantarflexion: MD = -37.1 N; abduction: -9.8 N), the clinical 
significance of these results should be interpreted with caution. Methods previously reported 
to measure hallux plantarflexion strength include the clinical paper grip test [53], strain gauge 
scales [54], force plate [55] or pressure platform systems [21]. We developed a novel method 
that would not only give a continuous-scaled quantitative measurement, but would also allow 
us to examine participants’ ability to abduct the hallux. 
 
Finally, some discussion is warranted regarding self-report data obtained in our study. Both 
foot-specific questionnaires (FHSQ, FPDI) produced significantly skewed data, and 
consequently non-parametric statistical tests were used. In particular the summed FPDI 
scores cannot be interpreted as a true interval scale unless a Rasch analysis is performed [36], 
which was not undertaken for the current study. Potential for recall bias and variation 
between individuals’ interpretation of pain rating scales should also be considered when 
interpreting self-report data [56, 57]. It is interesting to note that self-report measures of foot-
specific pain and disability showed large differences between groups, while self-reported 
general functioning and physical performance tests were less indicative of limitations in 
participants with HV. Study participants reported more pain and disability than was evident 
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on physical performance tests, thus it may be that foot-specific questionnaires (FHSQ, FPDI) 
capture more than typical measures used for physical function. For example, while general 
physical functioning (SF-36v2®), activity participation and walking performance were not 
impaired in this sample, HV subjects reported significant functional disability on the FPDI, 
which considers the influence of foot pain and other aspects such as walking distance and 
rough or hard surfaces. Future studies could utilise more challenging physical performance 
tasks to explore functional difficulty experienced by healthy adults with HV. 
 
Conclusion 
 
HV deformity is accompanied by significant foot-specific pain and disability, muscle 
weakness around the first MTPJ and increased mediolateral postural sway. Concerns 
regarding appearance and footwear are also important factors to consider for clinicians 
managing this common deformity. Global physical functioning and participation in activities 
were not adversely affected in our sample, indicating that HV may not prevent participation 
in an active lifestyle in otherwise healthy adults. 
 
List of abbreviations used 
 
BMI = body mass index 
CI = 95% confidence interval 
COP = centre of pressure 
FHSQ = Foot Health Status Questionnaire 
FPDI = Manchester Foot Pain and Disability Index 
HV = hallux valgus 
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ICC3,1 = intraclass correlation coefficient (3,1) 
MD = mean difference 
MDC90 = minimal detectable change (90% confidence limit) 
MTPJ = metatarsophalangeal joint 
OA = osteoarthritis 
PPT = pressure-pain threshold 
SD = standard deviation 
SEM = standard error of measurement 
SF-36v2® = Short Form 36 Health Survey, version 2 
VAS = visual analogue scale 
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Figures 
 
 
Figure 1 - Design of custom load cell frame for testing hallux plantarflexion and 
abduction strength; A) dorsal/anterior view, B) lateral view. 
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Figure 2 - Hallux plantarflexion and abduction strength for HV and control groups; * 
indicates a significant difference between groups (p < 0.001). 
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Tables 
Table 1. Characteristics of HV and control groups with comparison of SF-36v2® subscales 
and physical activity levels (mean ± SD, unless otherwise stated) 
 HV group 
(n = 30) 
Control group 
(n = 30) 
Mean difference  
(95% CI) 
Subject characteristics    
Men/Women (n) 5/25 5/25 NA 
Age (years) 44.5±15.2 44.2±15.3 0.3 (-7.6 to 8.2) 
BMI (kg/m2) 24.2±3.4 24.7±4.2 -0.5 (-2.5 to 1.5) 
HV angle (°)† 29.1±7.8 9.8±3.5 19.3 (16.2 to 22.4)** 
First MTPJ OA (n (right/left)) 1 (1/1) 2 (2/1) NA 
SF-36v2® (score range 0 – 100)    
Physical functioning 86.6±19.3 93.2±9.7 -6.6 (-14.5 to 1.3) 
Role-physical 87.5±17.9 93.3±13.7 -5.8 (-14.1 to 2.4) 
Role-emotional 93.1±11.4 93.9±11.1 -0.83 (-6.7 to 5.0) 
Bodily pain 75.0±18.8 81.8±14.0 -6.8 (-15.4 to 1.8) 
Vitality 59.4±17.3 67.1±12.2 -7.7 (-15.6 to 0.11) 
Mental health 79.7±10.8 83.5±11.0 -3.9 (-9.5 to 1.8) 
Social functioning 91.3±12.8 89.2±15.3 2.1 (-5.2 to 9.4) 
General health 78.5±17.2 78.8±13.1 -0.3 (-8.2 to 7.6) 
Physical activity (score range 1 – 5)    
Work 2.62±0.33 2.45±0.32 0.17 (0.0 to 0.34)* 
Sport 2.92±0.94 2.23±0.65 0.69 (0.28 to 1.1)* 
Leisure 2.87±0.63 2.88±0.55 -0.01 (-0.32 to 0.30) 
Abbreviations: HV = hallux valgus; CI = confidence interval; BMI = body mass index; MTPJ = 
metatarsophalangeal joint; OA = osteoarthritis; SF-36v2® = Short Form 36 Health Survey, version 2 
* P < 0.05 
** P < 0.001 
† Only one foot included in analysis (HV group: worst foot; control group: randomly chosen) 
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Table 2. Comparison between HV and control groups for self-reported foot pain, disability 
and concern about appearance (mean ± SD for all tests except FPDI presented as median 
(min – max)) 
 HV group 
(n = 30) 
Control group 
(n = 30) 
Mean difference  
(95% CI) 
FHSQ (score range 0 – 100)    
Foot pain scale 76.8±18.5 94.9±6.2 -18.1 (-25.3 to -11.0)** 
Foot function scale 86.9±17.7 99.4±2.5 -12.5 (-19.0 to -5.9)** 
Footwear scale 28.1±23.1 75.5±25.4 -47.5  (-60.0 to -34.9)** 
General foot health 49.1±29.0 86.6±13.9 -37.5 (-49.3 to -25.7)** 
VAS (0 – 100 mm)    
Worst pain VAS 37.6±25.5 12.2±16.9 25.5 (14.3 to 36.6)** 
Average pain VAS 15.4±15.1 3.2±6.9 12.3 (6.2 to 18.3)** 
Appearance VAS 58.4±31.4 20.4±23.2 38.1 (23.8 to 52.3)** 
Pressure-pain threshold (kPa)    
Medial first MTPJ 561.6±224.1 694.9±233.3 -133.3 (-251.5 to -15.1)* 
Plantar first MTPJ 448.7±196.8 539.5±231.5 -90.8 (-201.8 to 20.3) 
Footwear examination (mm)    
Relative heel height 15.2±11.8 16.2±12.3 -0.96 (-7.3 to 5.4) 
Relative ball width† 4.6±4.6 4.8±5.2 -0.22 (-3.1 to 2.6) 
FPDI   Wilcoxon rank-sum Z 
Function (score range 0 – 20) 2 (0 – 14) 0 (0 – 5) -4.88** 
Pain (score range 0 – 10) 3 (0 – 8) 0 (0 – 2) -5.81** 
Total (score range 0 – 34) 5.5 (0 – 24) 0 (0 – 9) -6.18** 
Abbreviations: HV = hallux valgus; CI = confidence interval; FHSQ = Foot Health Status 
Questionnaire; VAS = Visual analogue scale; MTPJ = metatarsophalangeal joint; FPDI = Foot Pain 
and Disability Index. 
* P < 0.05 
** P < 0.001 
† Twelve subjects were excluded from this analysis; therefore analysis was based on n = 48 (23 HV, 
25 control)   
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Table 3. Comparison between HV and control groups for functional performance and muscle 
strength (mean ± SD) 
 HV group 
(n = 30) 
Control group 
(n = 30) 
Mean difference  
(95% CI) 
Walking tests (sec)    
Timed 10m walk 4.95±0.69 4.99±0.59 -0.04 (-0.37 to 0.29) 
Stair ascent 3.88±0.41 3.77±0.41 0.11 (-0.11 to 0.32) 
Stair descent 3.58±0.45 3.46±0.44 0.12 (-0.11 to 0.35) 
Postural sway (COP range, cm)    
AP sway, both feet eyes open 1.91±0.82 1.90±0.62 0.0 (-0.37 to 0.38) 
ML sway, both feet eyes open  1.50±0.65 1.35±0.40 0.15 (-0.13 to 0.43) 
AP sway, both feet eyes closed 2.13±1.4 2.08±0.97 0.05 (-0.58 to 0.68) 
ML sway, both feet eyes closed 1.78±0.68 1.44±0.46 0.34 (0.04 to 0.63)* 
AP sway, foam eyes open 3.06±1.2 2.78±0.82 0.28 (-0.26 to 0.82) 
ML sway, foam eyes open 3.63±1.1 3.43±0.91 0.20 (-0.33 to 0.73) 
AP sway, foam eyes closed 5.94±3.3 4.87±1.4 1.1 (-0.24 to 2.4) 
ML sway, foam eyes closed 7.80±2.9 6.61±1.8 1.2 (-0.06 to 2.4) 
AP sway, single leg stance† 3.44±1.2 2.97±0.85 0.47 (-0.07 to 1.0) 
ML sway, single leg stance† 5.54±2.8 4.56±1.4 0.98 (-0.16 to 2.1) 
Muscle strength (N)    
Plantarflexion strength 66.9±29.0 104.0±40.7 -37.1 (-55.4 to -18.8)** 
Abduction strength 9.9±7.7 19.7±13.9 -9.8 (-15.6 to -4.0)** 
Abbreviations: HV = hallux valgus; CI = confidence interval; COP = centre of pressure; AP = 
anteroposterior; ML = mediolateral 
* P < 0.05 
** P < 0.001 
† Two excluded trials (< 30 sec) in HV group; therefore analysis was based on n = 58 
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Additional files 
 
Additional file 1. Test-retest reliability for physical measures 
Nix_Additional file 1.xls 
 
 Sample 
(n (n feet)) ICC (3,1) 95% CI SEM MDC90 
HV angle (°) 38 (76 feet) 0.99 0.99 to 1.0 1.1 2.7 
VAS appearance (mm) 14 0.84 0.68 to 0.92 12.6 29.4 
PPT plantar MTPJ (kPa) 11 (22 feet) 0.86 0.69 to 0.94 81.0 188.9 
PPT medial MTPJ (kPa) 11 (22 feet) 0.80 0.58 to 0.91 109.4 255.2 
Shoe heel height (mm) 11 0.99 0.97 to 1.0 1.0 2.4 
Shoe forefoot sole thickness (mm) 11 0.98 0.93 to 1.0 1.1 2.5 
Shoe ball width (mm) 11 0.97 0.90 to 0.99 0.8 2.0 
Foot ball width (mm) 11 0.98 0.95 to 0.99 1.1 2.6 
Stair ascent (sec) 9 0.90 0.61 to 0.98 0.2 0.4 
Stair descent (sec) 9 0.94 0.75 to 0.99 0.1 0.3 
Timed 10m walk (sec) 9 0.78 0.29 to 0.95 0.3 0.7 
Hallux plantarflexion (N) 16 (32 feet) 0.75 0.55 to 0.87 20.5 47.8 
Hallux abduction (N) 16 (32 feet) 0.73 0.51 to 0.86 6.2 14.5 
*Test-retest measures were taken a minimum of seven days apart 
Abbreviations: HV = hallux valgus; ICC = intraclass correlation coefficient; CI = confidence 
interval; SEM = standard error of measurement; MDC90 = minimal detectable change; VAS = visual 
analogue scale; PPT = pressure-pain threshold; MTPJ = metatarsophalangeal joint 
 
